American Century Companies Inc. Purchases 32,055 Shares of LifeVantage Co. (NASDAQ:LFVN)

American Century Companies Inc. lifted its holdings in LifeVantage Co. (NASDAQ:LFVN) by 50.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 95,552 shares of the company’s stock after purchasing an additional 32,055 shares during the quarter. American Century Companies Inc. owned 0.76% of LifeVantage worth $1,675,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Copeland Capital Management LLC purchased a new stake in LifeVantage in the fourth quarter worth about $65,000. Barclays PLC raised its holdings in shares of LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company’s stock valued at $507,000 after purchasing an additional 11,608 shares in the last quarter. HighTower Advisors LLC purchased a new stake in shares of LifeVantage in the 3rd quarter worth approximately $638,000. Ritholtz Wealth Management boosted its stake in shares of LifeVantage by 65.2% during the fourth quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock valued at $830,000 after purchasing an additional 18,682 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in LifeVantage by 43.9% during the fourth quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock valued at $1,300,000 after buying an additional 22,620 shares during the period. Institutional investors own 35.32% of the company’s stock.

LifeVantage Stock Up 10.4 %

Shares of LFVN stock opened at $15.30 on Thursday. LifeVantage Co. has a 52-week low of $5.22 and a 52-week high of $27.38. The stock has a market cap of $192.03 million, a PE ratio of 27.32 and a beta of 0.75. The business has a 50-day simple moving average of $16.86 and a 200-day simple moving average of $16.23.

LifeVantage (NASDAQ:LFVN) last posted its earnings results on Wednesday, February 5th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.08. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were given a dividend of $0.04 per share. The ex-dividend date was Monday, March 3rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 1.05%. LifeVantage’s payout ratio is currently 28.57%.

Insider Activity at LifeVantage

In other LifeVantage news, Director Raymond B. Greer sold 8,000 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $20.15, for a total transaction of $161,200.00. Following the sale, the director now owns 99,288 shares in the company, valued at $2,000,653.20. This represents a 7.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 20.65% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on LFVN. Craig Hallum initiated coverage on LifeVantage in a report on Tuesday, January 14th. They issued a “buy” rating and a $35.00 price target on the stock. Lake Street Capital began coverage on shares of LifeVantage in a report on Thursday, December 19th. They issued a “buy” rating and a $26.00 target price for the company.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.